Krause Kevin Michael sold ANTX
January 9, 2024 · Form 4 insider transaction
Krause Kevin Michael sold 7,417 shares of AN2 Therapeutics, Inc. at $20.14 per share, a transaction worth $149.4K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
7,417
Price
$20.14
Total value
$149.4K
InsiderKrause Kevin Michael
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateJanuary 9, 2024
Filing dateJanuary 11, 2024
Shares owned after1,914
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 28, 2023.; Price reported is a weighted-average sales price. The shares were sold at prices ranging from $20.00 to $20.33. The reporting person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.